SPHK1 and neoplasm: Inhibition of SphK1 activity (by siRNA or specific inhibitors) significantly reduces the metastatic phenotype of tumor cells, confirming that the SphK1/S1P/EDG1 signaling axis is a key regulatory hub for HCC metastasis (40).